1. Cysteine is an essential amino acid for newborn preterm infants; 2. Cysteine requirements change rapidly with postnatal age; 3. The change in cysteine requirement with age is based upon cystathionase activity; 4. Intestinal cystathionase…
ID
Bron
Verkorte titel
Ondersteuning
P.O. Box 2060
3000 CB Rotterdam
P.O. Box 2060
3000 CB Rotterdam
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
1. Fractional oxidation of 13C-phenylalanine;<br>
2. Whole body flux of 13C-phenylalanine.
Achtergrond van het onderzoek
Cysteine is considered to be a conditionally essential amino acid in premature infants. This is due to immaturity of the enzymatic pathway responsible for conversion of methionine to cysteine.
Cysteine plays a key role in glutathione synthesis which is a very important antioxidant. Many complications of premature birth are based upon oxidant damage.
In this study we will investigate the cysteine requirement in premature infants. Infants born with a gestational age of 26-29 weeks will be studied at a post-conceptional age of 30-32 weeks and at a post-conceptional age of 35-37 weeks. Infants born at a gestational age of 32-34 weeks will also be studied at a post-conceptional age of 35-37 weeks. Preterm infants with the above described characteristics regarding postnatal and gestational age will be fed testdiets with graded amounts of cystine.
Fractional oxidation will be measured using the Indicator Amino Acid Oxidation method.
Doel van het onderzoek
1. Cysteine is an essential amino acid for newborn preterm infants;
2. Cysteine requirements change rapidly with postnatal age;
3. The change in cysteine requirement with age is based upon cystathionase activity;
4. Intestinal cystathionase activity is of major importance for the conversion of methionine to cysteine.
Onderzoeksopzet
N/A
Onderzoeksproduct en/of interventie
Infants receive a testdiets with graded amounts of Cystine for 32 hours.
Publiek
room SP3433,
P.O. Box 2060
M.A. Riedijk
Rotterdam 3000 CB
The Netherlands
+31 (0)10 4636363
m.riedijk@erasmus.nl
Wetenschappelijk
room SP3433,
P.O. Box 2060
M.A. Riedijk
Rotterdam 3000 CB
The Netherlands
+31 (0)10 4636363
m.riedijk@erasmus.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Infants born with a gestational age of 26-29 weeks will be studied at a post-conceptional age of 30-32 weeks and at a post-conceptional age of 35-37 weeks.
2. Infants born at a gestational age of 32-34 weeks will also be studied at a post-conceptional age of 35-37 weeks.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Congenital metabolic disease;
2. Congenital anomalies;
3. Gastroinestinal diseases.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL208 |
NTR-old | NTR245 |
Ander register | : N/A |
ISRCTN | ISRCTN35832828 |
Samenvatting resultaten
2. Pediatrics. 2008 Mar;121(3):e561-7. Epub 2008 Feb 18. <br>